Introduction
Cellulitis, a prevalent bacterial skin infection, affects over 14 million individuals annually in the United States. This condition imposes a significant healthcare burden, accounting for approximately $3.7 billion in ambulatory care expenses and 650,000 hospitalizations each year.[1] Characterized by a poorly defined, warm, erythematous area accompanied by edema and tenderness, cellulitis involves acute bacterial invasion of the deep dermis and subcutaneous tissues. Importantly, it is distinguished by the absence of abscesses or purulent discharge. The primary culprits are beta-hemolytic streptococci, particularly group A streptococcus (Streptococcus pyogenes), and methicillin-sensitive Staphylococcus aureus. However, in immunocompromised patients, those colonized with methicillin-resistant Staphylococcus aureus (MRSA), or individuals with specific comorbidities such as diabetes mellitus, a broader range of bacteria may be implicated.[2] Accurate and timely Cellulitis Diagnosis is crucial for initiating appropriate antibiotic therapy and ensuring favorable patient outcomes. This article provides an in-depth guide to cellulitis, focusing on its diagnosis, etiology, evaluation, and management, designed to enhance the knowledge and skills of healthcare professionals.
Etiology of Cellulitis
The skin acts as a robust barrier, safeguarding the body from the external environment and preventing the entry of normal skin flora and pathogenic microbes into deeper tissues and the lymphatic system. However, when this protective barrier is breached, whether through skin injuries, surgical incisions, or other disruptions, bacteria can penetrate the dermis and subcutaneous tissue. This bacterial introduction beneath the skin surface can trigger an acute infection, leading to cellulitis. The most frequent causative agent is group A beta-hemolytic streptococcus (Streptococcus pyogenes).[3]
Several factors increase the risk of skin barrier compromise and subsequent cellulitis. These include skin trauma, surgical wounds, intravenous catheter insertion sites, interdigital fissures, insect and animal bites, and pre-existing skin infections.[4] Furthermore, individuals with underlying medical conditions such as diabetes mellitus, venous insufficiency, peripheral arterial disease, and lymphedema are at a heightened risk of developing cellulitis due to compromised skin integrity and/or impaired immune responses.[5]
Epidemiology of Cellulitis
Cellulitis is a common dermatological condition, particularly affecting middle-aged and older adults. Its incidence is considerable, with approximately 50 cases occurring per 1000 patient-years.[6] Notably, there is no significant difference in cellulitis incidence between men and women. The widespread occurrence of cellulitis underscores the importance of understanding its cellulitis diagnosis and management for healthcare providers across various specialties.
Pathophysiology of Cellulitis
The hallmark signs of cellulitis – erythema, warmth, edema, and tenderness – arise from the body’s inflammatory response to bacterial invasion. When bacteria penetrate the epidermis, they trigger a cascade of immune reactions involving cytokine release and neutrophil recruitment to the affected area. This epidermal response also includes the production of antimicrobial peptides and keratinocyte proliferation, contributing to the characteristic clinical presentation of cellulitis.[7] Group A Streptococci, a common cause of cellulitis, can exacerbate the disease through virulence factors like pyrogenic exotoxins (A, B, C, and F) and streptococcal superantigen, leading to more severe and invasive infections.[8]
History and Physical Examination in Cellulitis Diagnosis
A thorough history and physical examination are paramount in the cellulitis diagnosis process. Patients typically present with a skin area exhibiting poorly demarcated erythema, warmth, swelling, and tenderness. Systemic symptoms such as malaise, fatigue, and fever may also be present.
Clinicians should obtain a detailed history of the present illness, focusing on the onset and progression of skin changes. Crucial questions include recent travel, trauma, intravenous drug use, and insect or animal bites. A comprehensive past medical history is essential to identify predisposing conditions like diabetes mellitus, venous stasis, peripheral vascular disease, chronic tinea pedis, and lymphedema.
The physical examination should involve careful inspection of the affected area for skin breaks, demarcation of the erythematous area to monitor spread, and palpation for fluctuance indicative of abscess formation. Assessing warmth, tenderness, and purulent drainage is also vital. While cellulitis can occur anywhere on the body, it most commonly affects the lower extremities and is typically unilateral. In lower extremity cases, meticulous examination of interdigital spaces is necessary.[9] Furthermore, in extremity cellulitis, sensation and distal pulses should be assessed to rule out compartment syndrome. The presence of vesicles, bullae, peau d’orange, and lymphadenopathy should also be noted.
Evaluation and Cellulitis Diagnosis Criteria
Cellulitis diagnosis is primarily clinical, based on the characteristic signs of spreading erythematous inflammation in the deep dermis and subcutaneous tissue. The key diagnostic features are worsening erythema, edema, warmth, and tenderness. The presence of at least two of the four cardinal signs (warmth, erythema, edema, tenderness) is generally sufficient to establish a cellulitis diagnosis. While most common in the lower extremities, cellulitis can affect any body area and is typically unilateral. A thorough skin examination should seek potential entry points for bacteria, such as injuries, insect bites, pressure ulcers, or injection sites. In lower extremity cellulitis, interdigital fissures or tinea pedis should be carefully sought. Lymphadenopathy may also be present due to lymphatic involvement. Associated edema can lead to vesicles, bullae, and peau d’orange due to edema around hair follicles.
Guidelines from the Infectious Disease Society of America (IDSA) advise against routine imaging for cellulitis, reserving it for febrile neutropenic patients. Blood cultures are also not routinely recommended but should be considered in immunocompromised patients, those with immersion injuries or animal bites, and patients showing signs of systemic infection.[9, 8]
Treatment and Management of Cellulitis
Treatment strategies for cellulitis depend on the severity and clinical presentation. Patients with mild cellulitis without systemic signs of infection can typically be managed with oral antibiotics targeting streptococcal species and considering MSSA coverage. A minimum 5-day course of oral antibiotics is recommended. For nonpurulent cellulitis, cephalexin 500 mg every 6 hours is a suitable first-line agent. In cases of severe beta-lactam allergy, clindamycin 300 mg to 450 mg every 6 hours is an alternative.
For purulent cellulitis, cases with MRSA risk factors (MRSA colonization, abscess, puncture wounds, IV drug use history), antibiotics with MRSA coverage are necessary. Trimethoprim-sulfamethoxazole 800 mg/160 mg twice daily for 5 days, in conjunction with cephalexin 500 mg every 6 hours, is recommended. Clindamycin can be used as an alternative for trimethoprim-sulfamethoxazole allergy. A longer antibiotic course may be considered if improvement is minimal within 48 hours.
Hospitalization and intravenous antibiotics are indicated for patients with systemic infection signs*, outpatient treatment failure, immunocompromised status, rapidly progressing erythema, inability to tolerate oral medications, or cellulitis near indwelling devices.
Intravenous antibiotics should cover group A streptococci. In the absence of MRSA risk factors, cefazolin is appropriate, with potential de-escalation to oral cephalexin for a total of 5 days. If MRSA risk factors are present, vancomycin should be initiated, potentially de-escalating to oral trimethoprim/sulfamethoxazole.
Immunocompromised patients requiring hospitalization may need broad-spectrum coverage, such as vancomycin plus piperacillin-tazobactam or a carbapenem. Blood cultures are recommended in systemic toxicity, persistent cellulitis, or specific exposures like animal bites or water-related injuries.[10]
Atypical organisms can cause cellulitis in specific contexts. Pasteurella multocida is associated with dog or cat bites. Vibrio vulnificus can cause cellulitis from water-related injuries like oyster shell cuts. Pseudomonas aeruginosa is a risk in diabetic patients, especially with foot ulcers, and in immunocompromised individuals, who are also at risk for Cryptococcus.
In patients with significant edema, addressing the underlying cause is crucial. Elevation of the affected area is also recommended.[9]
* Systemic inflammatory response criteria include two or more of: fever (>38°C), tachycardia (>90 bpm), tachypnea (>20 breaths/min), leukocytosis (>12,000/mm³), leukopenia (<4,000/mm³), or bandemia (≥10%).[9]
Differential Diagnosis of Cellulitis
Accurate cellulitis diagnosis requires differentiation from several conditions that can mimic its presentation.
Erysipelas, sometimes considered a superficial form of cellulitis, affects the upper dermis and superficial lymphatics. Distinguishing features include bright red erythema, skin elevation, and well-demarcated borders, contrasting with cellulitis’s milder erythema (pink), flatness, and less distinct borders. Erysipelas may also exhibit lymphatic streaking and is primarily caused by group A streptococcus. First-line treatment is amoxicillin or cephalexin.
Chronic venous stasis dermatitis, associated with venous insufficiency, is typically bilateral and chronic, often involving the medial malleoli. It presents with erythema, scaling, hyperpigmentation, and edema. Treatment focuses on managing the underlying venous insufficiency.
Necrotizing fasciitis, a rare but severe infection of the fascia and subcutaneous tissue, presents with fever, erythema, edema, pain disproportionate to examination findings, and crepitus. It is a surgical emergency requiring immediate debridement. Imaging, such as CT scans showing subcutaneous gas, can aid diagnosis but should not delay surgery.
Septic arthritis, an infected joint, commonly affects the knee, presenting with joint swelling, warmth, pain, and limited mobility. Diagnosis involves joint aspiration, and treatment includes antibiotics targeting common pathogens.
Deep vein thrombosis (DVT) is typically unilateral, with tenderness, erythema, warmth, and edema, often in the lower extremities. DVT risk factors are usually present. While fever and leukocytosis are rare, they can occur. Ultrasound confirms the diagnosis.[4]
Prognosis of Cellulitis
With prompt cellulitis diagnosis and appropriate antibiotic treatment, patients usually show improvement within 48 hours. However, recurrence is common, occurring annually in 8-20% of patients and reaching cumulative rates as high as 49%.[7, 1] Recurrence can be reduced through prompt management of skin breaks, good hygiene, and addressing underlying comorbidities. Initial antibiotic treatment failure occurs in approximately 18% of cases. Overall, cellulitis prognosis is generally good with timely and appropriate intervention.[11]
Complications of Untreated Cellulitis
Without timely cellulitis diagnosis and treatment, complications can arise. Bacteremia, bacterial infection of the bloodstream, can occur, diagnosed by blood cultures in systemically ill patients. Untreated bacteremia can progress to endocarditis, an infection of the heart’s inner lining. Sepsis can develop in patients with cellulitis and systemic inflammatory response syndrome (SIRS) criteria. Osteomyelitis, bone infection, can occur if cellulitis spreads to the bone. These complications necessitate prolonged antibiotic courses and potentially surgery.[1]
Deterrence and Patient Education for Cellulitis
Patient education is vital for cellulitis management and prevention. Patients should adhere to prescribed antibiotic regimens, keep the affected area clean and dry, and elevate it to reduce edema. Improvement should be expected within 24-48 hours of antibiotic initiation. Patients should be instructed to seek medical attention if erythema spreads, symptoms worsen or don’t improve, persistent fever develops, bullae appear, or pain intensifies.[9] Maintaining good hand hygiene and promptly cleaning skin abrasions are also crucial preventive measures.[13]
Enhancing Healthcare Team Outcomes in Cellulitis Management
Optimal cellulitis management requires an interprofessional team approach involving physicians, pharmacists, nurses, and wound care specialists. Pharmacists, particularly infectious disease specialists, can optimize antibiotic selection. Most patients can be managed as outpatients. Inpatient management requires collaboration to ensure accurate cellulitis diagnosis and appropriate treatment. Nurses monitor symptoms and demarcate erythema. Pharmacists assist with antibiotic dosing and monitoring, especially for potentially nephrotoxic agents like vancomycin. Wound care nurses educate patients on skin care, elevation, and mobility to prevent DVT. Collaborative care and patient education are essential for successful treatment and preventing recurrence.[14, 15]
Review Questions
Figure: Cellulitis Clinical Presentation
Figure: Chronic Venous Insufficiency Differential
Figure: Extremity Cellulitis Example
Figure: Erysipelas Clinical Features
References
1.Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA. 2016 Jul 19;316(3):325-37. [PubMed: 27434444]
2.Cranendonk DR, Lavrijsen APM, Prins JM, Wiersinga WJ. Cellulitis: current insights into pathophysiology and clinical management. Neth J Med. 2017 Nov;75(9):366-378. [PubMed: 29219814]
3.Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF., Infectious Diseases Society of America. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011 Feb 01;52(3):e18-55. [PubMed: 21208910]
4.Quirke M, Ayoub F, McCabe A, Boland F, Smith B, O’Sullivan R, Wakai A. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol. 2017 Aug;177(2):382-394. [PubMed: 27864837]
5.Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis. 2019 Apr 08;68(Suppl 3):S193-S199. [PMC free article: PMC6452002] [PubMed: 30957165]
6.McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez JW, Mirzoyev SA, Baddour LM. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. Mayo Clin Proc. 2007 Jul;82(7):817-21. [PubMed: 17605961]
7.Richmond JM, Harris JE. Immunology and skin in health and disease. Cold Spring Harb Perspect Med. 2014 Dec 01;4(12):a015339. [PMC free article: PMC4292093] [PubMed: 25452424]
8.Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000 Jul;13(3):470-511. [PMC free article: PMC88944] [PubMed: 10885988]
9.Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014 Jul 15;59(2):147-59. [PubMed: 24947530]
10.Torres J, Avalos N, Echols L, Mongelluzzo J, Rodriguez RM. Low yield of blood and wound cultures in patients with skin and soft-tissue infections. Am J Emerg Med. 2017 Aug;35(8):1159-1161. [PubMed: 28592371]
11.Obaitan I, Dwyer R, Lipworth AD, Kupper TS, Camargo CA, Hooper DC, Murphy GF, Pallin DJ. Failure of antibiotics in cellulitis trials: a systematic review and meta-analysis. Am J Emerg Med. 2016 Aug;34(8):1645-52. [PubMed: 27344098]
12.Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect. 2012 Feb;64(2):148-55. [PubMed: 22101078]
13.Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004 Feb 26;350(9):904-12. [PubMed: 14985488]
14.Singh M, Negi A, Zadeng Z, Verma R, Gupta P. Long-Term Ophthalmic Outcomes in Pediatric Orbital Cellulitis: A Prospective, Multidisciplinary Study From a Tertiary-Care Referral Institute. J Pediatr Ophthalmol Strabismus. 2019 Sep 01;56(5):333-339. [PubMed: 31545868]
15.Gibbons JA, Smith HL, Kumar SC, Duggins KJ, Bushman AM, Danielson JM, Yost WJ, Wadle JJ. Antimicrobial stewardship in the treatment of skin and soft tissue infections. Am J Infect Control. 2017 Nov 01;45(11):1203-1207. [PubMed: 28732743]
